Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The immunopeptidome landscape associated with T cell infiltration, inflammation and immune editing in lung cancer
Anne I. Kraemer, Chloé Chong, Florian Huber, et al.
Nature Cancer (2023) Vol. 4, Iss. 5, pp. 608-628
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Challenges in developing personalized neoantigen cancer vaccines
Peter D. Katsikis, Ken J. Ishii, Christopher Schliehe
Nature reviews. Immunology (2023) Vol. 24, Iss. 3, pp. 213-227
Closed Access | Times Cited: 77
Liquid biopsy techniques and lung cancer: diagnosis, monitoring and evaluation
Fei Ren, Qian Fei, Kun Qiu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 28
Immunopeptidomics-based identification of naturally presented non-canonical circRNA-derived peptides
Humberto J. Ferreira, Brian J. Stevenson, HuiSong Pak, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 16
RNA vaccines for cancer: Principles to practice
Pablo Guasp, Charlotte Reiche, Zachary Sethna, et al.
Cancer Cell (2024) Vol. 42, Iss. 7, pp. 1163-1184
Closed Access | Times Cited: 11
Current Landscape of Cancer Immunotherapy: Harnessing the Immune Arsenal to Overcome Immune Evasion
Ankita Mitra, Anoop Kumar, Nitin Amdare, et al.
Biology (2024) Vol. 13, Iss. 5, pp. 307-307
Open Access | Times Cited: 9
Immune checkpoint blockade resistance in lung cancer: emerging mechanisms and therapeutic opportunities
Jessica Konen, Haoyi Wu, Don L. Gibbons
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 6, pp. 520-536
Closed Access | Times Cited: 8
Unlocking the potential of microfluidics in mass spectrometry-based immunopeptidomics for tumor antigen discovery
Charlotte Stutzmann, Jiaxi Peng, Zhaoguan Wu, et al.
Cell Reports Methods (2023) Vol. 3, Iss. 6, pp. 100511-100511
Open Access | Times Cited: 17
TOFIMS mass spectrometry-based immunopeptidomics refines tumor antigen identification
Naomi Hoenisch Gravel, Annika Nelde, Jens Bauer, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 17
A comprehensive proteogenomic pipeline for neoantigen discovery to advance personalized cancer immunotherapy
Florian Huber, Marion Arnaud, Brian J. Stevenson, et al.
Nature Biotechnology (2024)
Open Access | Times Cited: 5
Convergent inducers and effectors of T cell paralysis in the tumour microenvironment
Douglas Hanahan, Olivier Michielin, Mikaël J. Pittet
Nature reviews. Cancer (2024)
Closed Access | Times Cited: 5
Significance of LRFN4 in prognosis and tumor microenvironment of lung adenocarcinoma
Nana Wang, Shuming Cao, Xiaofeng Tan, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Deleterious knock-outs in the HLA class I antigen processing and presentation machinery induce distinct changes in the immunopeptidome
Ilja E. Shapiro, Clélia Maschke, Justine Michaux, et al.
Molecular & Cellular Proteomics (2025), pp. 100951-100951
Open Access
Spatial transcriptomics in cancer research and potential clinical impact: a narrative review
Michael A. Cilento, Christopher J. Sweeney, Lisa M. Butler
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 6
Open Access | Times Cited: 4
Hypoxia promotes tumor immune evasion by suppressing MHC-I expression and antigen presentation
Hala Estephan, Arun Tailor, Robert Parker, et al.
The EMBO Journal (2025) Vol. 44, Iss. 3, pp. 903-922
Open Access
Coordinated immune networks in leukemia bone marrow microenvironments distinguish response to cellular therapy
Katie Maurer, Cameron Y. Park, Shouvik Mani, et al.
Science Immunology (2025) Vol. 10, Iss. 103
Closed Access
Multimodal diagnostic models and subtype analysis for neoadjuvant therapy in breast cancer
Zheng Ye, Jiaqi Yuan, Deqing Hong, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
The SysteMHC Atlas v2.0, an updated resource for mass spectrometry-based immunopeptidomics
Xiaoxiang Huang, Ziao Gan, Haowei Cui, et al.
Nucleic Acids Research (2023) Vol. 52, Iss. D1, pp. D1062-D1071
Open Access | Times Cited: 11
Breast cancer immunopeptidomes contain numerous shared tumor antigens
Eralda Kina, Jean‐Philippe Laverdure, Chantal Durette, et al.
Journal of Clinical Investigation (2023) Vol. 134, Iss. 1
Open Access | Times Cited: 10
Coordinated Immune Cell Networks in the Bone Marrow Microenvironment Define the Graft versus Leukemia Response with Adoptive Cellular Therapy
Katie Maurer, Cameron Y. Park, Shouvik Mani, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Are we getting closer to a successful neoantigen cancer vaccine?
Karen Manoutcharian, Goar Gevorkian
Molecular Aspects of Medicine (2024) Vol. 96, pp. 101254-101254
Closed Access | Times Cited: 3
Emerging potential of immunopeptidomics by mass spectrometry in cancer immunotherapy
Yuriko Minegishi, Yoshimi Haga, Koji Ueda
Cancer Science (2024) Vol. 115, Iss. 4, pp. 1048-1059
Open Access | Times Cited: 3
Predicting the mechanism of action of YQYYJD prescription in the treatment of non-small cell lung cancer using transcriptomics analysis
Yinan Yin, Yichao Wang, Chengyan Wang, et al.
Journal of Ethnopharmacology (2024) Vol. 326, pp. 117984-117984
Closed Access | Times Cited: 2
Unveiling major histocompatibility complex-mediated pan-cancer immune features by integrated single-cell and bulk RNA sequencing
Hao-Ran Feng, Xiaonan Shen, Xiaoming Zhu, et al.
Cancer Letters (2024) Vol. 597, pp. 217062-217062
Closed Access | Times Cited: 2
Proteogenomics offers a novel avenue in neoantigen identification for cancer immunotherapy
Yuqing Ren, Yi Yue, Xinyang Li, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113147-113147
Closed Access | Times Cited: 2
ImmuneApp for HLA-I epitope prediction and immunopeptidome analysis
Haodong Xu, Ruifeng Hu, Xianjun Dong, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top